Type to search

Onxeo Appoints Julien Miara as New Interim CEO | Pharmtech Focus
Onxeo Receives Notice of Allowance for a New Patent Broadening the Protection of AsiDNA™ in combination with a PARP Inhibitor in the United States | Pharmtech Focus